What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search News As of 2019, Vall d'Hebron will become the headquarters of ICORD, a worldwide reference organization in rare diseases From January 2019, Vall d'Hebron Barcelona Hospital Campus is taking over as the headquarters and coordinator of the International Conference on Rare Diseases and Orphan Drugs (ICORD). At the last meeting held in September in Stockholm, the members of the ICORD committee unanimously decided that News Vall d'Hebron performs the first pancreatic tail resection with the Da Vinci robot The Hepatobiliopancreatic Surgery Service of Vall d'Hebron Hospital has performed the first pancreatic resection of a pancreatic tail tumor using a first generation Da Vinci robot. News Genetic predisposition favors cannabis use in people with ADHD People with ADHD are almost eight times more likely to use cannabis throughout their lives. The study has described four shared genetic regions in both disorders. The prevalence rate of substance use disorder in adult ADHD is 45%. News Vall d'Hebron is leader in scientific publication in the open institutional repository Scientia The repository allows scientific production to be accessible to all citizens. News Activitats el 14 de febrer amb motiu de la commemoració del Dia Internacional de les Cardiopaties Congènites D'11.00 a 13.00 hores, els nens i nenes podran gaudir d'activitats al vestíbul de la planta baixa de l’Hospital Infantil. News The DISCOvERIE project, led by Vall d'Hebron, will provide an enhanced understanding on IBS and comorbidities and the risk factors The project will determine mechanisms of intestinal and central nervous system function underlying comorbidities in IBS and their interaction with the peripheral microbiota-gut-brain axis. News Vall d'Hebron obtains more than €1 million in profit from the use of a patent licence The biggest profit generated by a State Research Institute for a patent and it will be entirely reinvested in the VHIR's research. News Vall d’Hebron participates in an international study that completes the largest genetic map of psychiatric disorders so far The study analyzes the shared genetic basis of eight psychiatric pathologies and defines three groups of genetically related disorders. News Vall d'Hebron participates in an international position statement on the use of antihypertensive drugs in COVID-19 patients Currently, in the absence of scientific evidence, a withdrawal of ACEis or ARBs is not recommended in hypertensive patients. News Vall d'Hebron participates in two clinical trials against the coronavirus using Remdesivir The clinical trials are indicated for patients with severe and moderate respiratory diseases and they are coordinated by Dr Benito Almirante and Dr Ricard Ferrer. Pagination Previous page ‹‹ Page 111 Next page ››